Platysma Prominence: Review and Expert Analysis of Clinical Presentation, Burden, and Treatment Considerations
PP is a bothersome condition with a detrimental impact on patient quality of life and psychological and emotional well-being. OnabotulinumtoxinA is a nonsurgical treatment option with a record of safe, consistent results in treating PP.
Authors
- Sandhya Shimoga (ORCID: https://orcid.org/0000-0002-8039-3806)
- Dario Bertossi (ORCID: https://orcid.org/0000-0002-8635-9967)
- Zbigniew Lorenc (ORCID: https://orcid.org/0000-0002-3192-4789)
- Jean Carruthers (ORCID: https://orcid.org/0000-0002-3838-6768)
- René Hopfinger (ORCID: https://orcid.org/0000-0003-3291-6198)
- Elena Dimitrijević
- André Braz (ORCID: https://orcid.org/0000-0003-1100-8027)
- Koenraad De Boulle
- Ada Trindade de Almeida
Institutions
- University of Verona (IT)
- Spinal Cord Injury BC (CA)
- AbbVie (United States) (US)
- Onze Lieve Vrouwziekenhuis Hospital (BE)
- Allergan (United States) (US)
Publication Details
- Journal
- Plastic & Reconstructive Surgery Global Open
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1097/gox.0000000000006490
- Citations
- 2
- Primary Topic
- Facial Rejuvenation and Surgery Techniques
- Type
- article
- Field-Weighted Citation Impact
- 4.01